Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Choosing a total market fund for a Roth IRA doesn't have to be hard. Compare options, fees, and diversification to build a solid retirement strategy.
28,468 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Oil spikes can move markets quickly, pushing indexes lower. Yet even with a sharp price surge, the selloff often rema...
Vinod Khosla stepped in after Elon Musk pulled back from OpenAI’s pledge, funding a high-stakes bet that transformed ...
Central Valley peach growers confront a costly and abrupt pivot after Del Monte closures. About 3,000 acres will be u...
Nebius stock skyrocketed more, driven by demand for AI infrastructure. This guide breaks down the drivers, the number...
A single insider purchase can spark questions about a stock, but it isn’t a sure shot signal. This article digs into ...
Apple has delivered outsized gains since Tim Cook took the helm. A $10,000 stake from that era would sit on a hefty b...
Versant Media Group launches a CNBC-based direct-to-consumer platform for retail investors, pairing journalism with A...
This comprehensive analysis breaks down Coinbase's Q1 2026 earnings, explaining revenue mix, margins, and the outlook...
Dollar Tree beat expectations and raised its full-year outlook, sending its shares higher as fewer shoppers visit, bu...
Two high-growth names face near-term headwinds. This guide explains why patient investors could benefit from the pull...
A small board-game importer plans to manufacture Monopoly in the United States after tariffs push production home, a ...